Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply.
Saved in:
| Title: | Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply. |
|---|---|
| Authors: | Chow PKH; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore; Program in Translational and Liver Cancer Research, National Cancer Centre Singapore, Singapore 168583. Electronic address: pierce.chow@duke-nus.edu.sg., Hack SP; Genentech, San Francisco, CA, USA., Spahn JH; Genentech, San Francisco, CA, USA., Yopp AC; Department of Surgery, Division of Surgical Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. |
| Source: | Lancet (London, England) [Lancet] 2024 Aug 17; Vol. 404 (10453), pp. 657-658. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39153815 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chow+PKH%22">Chow PKH</searchLink>; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore; Program in Translational and Liver Cancer Research, National Cancer Centre Singapore, Singapore 168583. Electronic address: pierce.chow@duke-nus.edu.sg.<br /><searchLink fieldCode="AU" term="%22Hack+SP%22">Hack SP</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Spahn+JH%22">Spahn JH</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yopp+AC%22">Yopp AC</searchLink>; Department of Surgery, Division of Surgical Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2024 Aug 17; Vol. 404 (10453), pp. 657-658. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39153815 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(24)00801-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 657 Titles: – TitleFull: Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chow PKH – PersonEntity: Name: NameFull: Hack SP – PersonEntity: Name: NameFull: Spahn JH – PersonEntity: Name: NameFull: Yopp AC IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 08 Text: 2024 Aug 17 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 404 – Type: issue Value: 10453 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |
